Venus Concept (VERO) Competitors $0.30 0.00 (-0.99%) (As of 11:20 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends VERO vs. NURO, PXDT, PSTV, INBS, BTCY, CUTR, STSS, AEMD, CTCX, and CHEKShould you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include NeuroMetrix (NURO), Pixie Dust Technologies (PXDT), Plus Therapeutics (PSTV), Intelligent Bio Solutions (INBS), Biotricity (BTCY), Cutera (CUTR), Sharps Technology (STSS), Aethlon Medical (AEMD), Carmell (CTCX), and Check-Cap (CHEK). These companies are all part of the "medical equipment" industry. Venus Concept vs. NeuroMetrix Pixie Dust Technologies Plus Therapeutics Intelligent Bio Solutions Biotricity Cutera Sharps Technology Aethlon Medical Carmell Check-Cap NeuroMetrix (NASDAQ:NURO) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, community ranking, media sentiment, risk, profitability, analyst recommendations and dividends. Does the MarketBeat Community favor NURO or VERO? NeuroMetrix received 250 more outperform votes than Venus Concept when rated by MarketBeat users. However, 65.38% of users gave Venus Concept an outperform vote while only 58.80% of users gave NeuroMetrix an outperform vote. CompanyUnderperformOutperformNeuroMetrixOutperform Votes28458.80% Underperform Votes19941.20% Venus ConceptOutperform Votes3465.38% Underperform Votes1834.62% Do insiders & institutionals hold more shares of NURO or VERO? 19.4% of NeuroMetrix shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 7.3% of NeuroMetrix shares are owned by insiders. Comparatively, 58.0% of Venus Concept shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has stronger valuation and earnings, NURO or VERO? NeuroMetrix has higher earnings, but lower revenue than Venus Concept. NeuroMetrix is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroMetrix$5.90M1.48-$6.53M-$4.59-0.93Venus Concept$76.35M0.03-$37.25M-$8.02-0.04 Is NURO or VERO more profitable? Venus Concept has a net margin of -74.62% compared to NeuroMetrix's net margin of -203.71%. Venus Concept's return on equity of 0.00% beat NeuroMetrix's return on equity.Company Net Margins Return on Equity Return on Assets NeuroMetrix-203.71% -42.56% -39.26% Venus Concept -74.62%N/A -47.46% Which has more risk & volatility, NURO or VERO? NeuroMetrix has a beta of 2.29, suggesting that its stock price is 129% more volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Does the media refer more to NURO or VERO? In the previous week, Venus Concept had 2 more articles in the media than NeuroMetrix. MarketBeat recorded 3 mentions for Venus Concept and 1 mentions for NeuroMetrix. NeuroMetrix's average media sentiment score of 0.00 beat Venus Concept's score of -0.16 indicating that NeuroMetrix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NeuroMetrix 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Venus Concept 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryVenus Concept beats NeuroMetrix on 8 of the 15 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get Venus Concept News Delivered to You Automatically Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERO vs. The Competition Export to ExcelMetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.20M$4.42B$5.06B$8.82BDividend YieldN/A41.17%5.18%4.07%P/E Ratio-0.0424.81126.3117.81Price / Sales0.0347.031,178.7474.57Price / CashN/A51.8733.8632.53Price / Book-0.124.974.684.68Net Income-$37.25M$13.76M$119.54M$226.08M7 Day Performance-13.18%-1.08%-1.83%-1.04%1 Month Performance-34.60%0.58%-3.60%1.04%1 Year Performance-81.86%50.91%31.91%26.28% Venus Concept Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VEROVenus Concept1.305 of 5 stars$0.30-1.0%N/A-81.9%$2.18M$76.35M-0.04410Gap DownNURONeuroMetrix0.5208 of 5 stars$4.27-1.6%N/A+11.5%$8.71M$5.90M0.0020Analyst ForecastNews CoveragePXDTPixie Dust Technologies1.9685 of 5 stars$0.58flat$5.21+798.3%N/A$8.63M$6.30M0.0078Upcoming EarningsPSTVPlus Therapeutics3.2264 of 5 stars$1.22+2.5%$14.00+1,047.8%-37.4%$7.20M$4.91M0.0020Analyst RevisionGap UpINBSIntelligent Bio Solutions0.3287 of 5 stars$1.62+15.7%N/A-61.1%$7.11M$3.11M0.0010News CoverageGap UpBTCYBiotricityN/A$0.31-2.0%N/A-66.9%$6.98M$12.06M-0.2340Analyst ForecastAnalyst RevisionNews CoverageCUTRCutera1.11 of 5 stars$0.32+4.3%$3.00+851.2%-86.7%$6.37M$212.37M-0.05430Analyst ForecastGap DownSTSSSharps Technology0.7782 of 5 stars$3.23flatN/AN/A$5.81MN/A-0.383Gap DownAEMDAethlon Medical2.6602 of 5 stars$0.38-2.0%$7.00+1,732.5%-77.2%$5.33M$570,000.00-0.1410CTCXCarmellN/A$0.24-1.9%N/A-90.9%$5.04MN/A0.0014CHEKCheck-Cap0.5192 of 5 stars$0.79+3.7%N/A-76.9%$4.62MN/A-0.2780Upcoming EarningsNews CoverageGap Up Related Companies and Tools Related Companies NURO Alternatives PXDT Alternatives PSTV Alternatives INBS Alternatives BTCY Alternatives CUTR Alternatives STSS Alternatives AEMD Alternatives CTCX Alternatives CHEK Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VERO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
